Accord Healthcare Offers Generic Option For Treatment Of Schizophrenia & Bipolar Depression

Accord Healthcare, Inc. (Accord), a leading generic pharmaceutical company, has added Lurasidone hydrochloric acid (HCL) tablets to its line of generic drugs. Accord's product is AB-rated to Sunovion Pharma's Latuda® and is being offered in 20mg, 40mg, 60mg, 80mg, and 120mg doses in 30-count bottles. Lurasidone is an oral, atypical antipsychotic, which is a first-line treatment option for the management of schizophrenia and bipolar depression in adults and adolescents. Atypical antipsychotics have lower potential for extrapyramidal side effects. Lurasidone rebalances dopamine and serotonin to improve thinking, mood, and behavior.

Adverse reactions of lurasidone for treatment . . .